CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 67 filers reported holding CIDARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,569 | -16.6% | 127,965 | 0.0% | 0.00% | – |
| Q2 2023 | $144,600 | +1.7% | 127,965 | +14.3% | 0.00% | – |
| Q1 2023 | $142,165 | +78.2% | 111,941 | +6.1% | 0.00% | – |
| Q4 2022 | $79,782 | +20.9% | 105,490 | 0.0% | 0.00% | – |
| Q3 2022 | $66,000 | +37.5% | 105,490 | +7.2% | 0.00% | – |
| Q2 2022 | $48,000 | -41.5% | 98,393 | 0.0% | 0.00% | – |
| Q1 2022 | $82,000 | -41.4% | 98,393 | -11.0% | 0.00% | – |
| Q4 2021 | $140,000 | -10.3% | 110,497 | +58.5% | 0.00% | – |
| Q3 2021 | $156,000 | +6.8% | 69,722 | -3.7% | 0.00% | – |
| Q2 2021 | $146,000 | -85.3% | 72,428 | -80.7% | 0.00% | – |
| Q1 2021 | $996,000 | +27.7% | 374,406 | -4.0% | 0.00% | – |
| Q4 2020 | $780,000 | -28.9% | 390,018 | +1.3% | 0.00% | – |
| Q3 2020 | $1,097,000 | +151.6% | 384,937 | +226.2% | 0.00% | – |
| Q2 2020 | $436,000 | +263.3% | 118,014 | +143.7% | 0.00% | – |
| Q1 2020 | $120,000 | +7.1% | 48,423 | +65.6% | 0.00% | – |
| Q4 2019 | $112,000 | +124.0% | 29,236 | +16.4% | 0.00% | – |
| Q3 2019 | $50,000 | +13.6% | 25,107 | -3.6% | 0.00% | – |
| Q2 2019 | $44,000 | -44.3% | 26,049 | -12.1% | 0.00% | – |
| Q1 2019 | $79,000 | -22.5% | 29,624 | -31.7% | 0.00% | – |
| Q4 2018 | $102,000 | -46.3% | 43,380 | +0.6% | 0.00% | – |
| Q3 2018 | $190,000 | -2.6% | 43,121 | +15.3% | 0.00% | – |
| Q2 2018 | $195,000 | +37.3% | 37,386 | +5.1% | 0.00% | – |
| Q1 2018 | $142,000 | +19.3% | 35,581 | +102.5% | 0.00% | – |
| Q4 2017 | $119,000 | -19.0% | 17,567 | -3.2% | 0.00% | – |
| Q3 2017 | $147,000 | +7.3% | 18,140 | -0.1% | 0.00% | – |
| Q2 2017 | $137,000 | -84.4% | 18,156 | -83.9% | 0.00% | – |
| Q1 2017 | $878,000 | -20.3% | 112,536 | +6.2% | 0.00% | – |
| Q4 2016 | $1,101,000 | +0.5% | 105,922 | +10.6% | 0.00% | – |
| Q3 2016 | $1,096,000 | +10.8% | 95,764 | -0.2% | 0.00% | – |
| Q2 2016 | $989,000 | +55.0% | 95,934 | +91.0% | 0.00% | – |
| Q1 2016 | $638,000 | -25.8% | 50,217 | +0.1% | 0.00% | – |
| Q4 2015 | $860,000 | +43.6% | 50,143 | +6.6% | 0.00% | – |
| Q3 2015 | $599,000 | – | 47,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |